• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Does proof of casualty ever exist in pharmacovigilance?

作者信息

Auriche M, Loupi E

机构信息

Department of Postmarketing Surveillance, Pasteur Mérieux Serums and Vaccines, Lyon, France.

出版信息

Drug Saf. 1993 Sep;9(3):230-5. doi: 10.2165/00002018-199309030-00008.

DOI:10.2165/00002018-199309030-00008
PMID:8240728
Abstract

Identifying the adverse effects of drugs, thus transforming adverse events into adverse drug reactions, is a useful and necessary but complicated task. Objective proof of a causal relationship between a drug and a specific event is quite exceptional. In most cases, this relationship remains subjective and is no more than inner conviction. Several means are at our disposal to achieve causal assessment: spontaneous reporting, clinical trials, cohorts with and without controls, and case-control studies, with each having advantages and limitations. The search for casualty in pharmacovigilance is a necessary scientific goal, but a high degree of suspicion may be all that is necessary to withdraw a drug from the market if it is suspected of causing serious adverse effects.

摘要

相似文献

1
Does proof of casualty ever exist in pharmacovigilance?
Drug Saf. 1993 Sep;9(3):230-5. doi: 10.2165/00002018-199309030-00008.
2
[The French pharmacovigilance system: structure and missions].[法国药物警戒系统:结构与使命]
Presse Med. 2000 Jan 22;29(2):102-6.
3
[Analysis of Spontaneously Reported Adverse Events].[自发报告不良事件分析]
Yakugaku Zasshi. 2016;136(4):549-56. doi: 10.1248/yakushi.15-00224-5.
4
Updating the French method for the causality assessment of adverse drug reactions.更新药品不良反应因果关系评估的法国方法。
Therapie. 2013 Mar-Apr;68(2):69-76. doi: 10.2515/therapie/2013016. Epub 2013 Jun 18.
5
Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria.药物警戒与药物流行病学中的因果关联:关于奥斯汀·布拉德福德·希尔标准应用的思考
Drug Saf. 2002;25(6):467-71. doi: 10.2165/00002018-200225060-00012.
6
Post-marketing drug withdrawals: Pharmacovigilance success, regulatory problems.药品上市后撤市:药物警戒的成功与监管问题
Therapie. 2017 Oct;72(5):555-561. doi: 10.1016/j.therap.2017.02.005. Epub 2017 Mar 30.
7
Causal or casual? The role of causality assessment in pharmacovigilance.因果关系还是偶然关系?因果关系评估在药物警戒中的作用。
Drug Saf. 1997 Dec;17(6):374-89. doi: 10.2165/00002018-199717060-00004.
8
Principles of signal detection in pharmacovigilance.药物警戒中的信号检测原则。
Drug Saf. 1997 Jun;16(6):355-65. doi: 10.2165/00002018-199716060-00002.
9
[Adverse drug reactions following immunization in Germany pursuant to the German Infection Protection Act and the German Medicinal Products Act from January 1, 2004 to December 31, 2005].[2004年1月1日至2005年12月31日德国依据《德国感染保护法》和《德国药品法》进行免疫接种后的药物不良反应]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 Nov;50(11):1404-17. doi: 10.1007/s00103-007-0368-6.
10
Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance.应用布拉德福德·希尔标准评估西沙必利所致心律失常的因果关系:药物警戒中评估因果关联的一个模型
Drug Saf. 2007;30(4):333-46. doi: 10.2165/00002018-200730040-00006.

引用本文的文献

1
Antibiotics and allergic disorders in childhood.儿童期的抗生素与过敏性疾病
Open Nurs J. 2008;2:48-57. doi: 10.2174/1874434600802010048. Epub 2008 May 22.
2
Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital.入住医学重症监护病房时危及生命的药物不良反应:一家教学医院的前瞻性研究
Intensive Care Med. 2007 Dec;33(12):2150-7. doi: 10.1007/s00134-007-0787-8. Epub 2007 Jul 25.
3
Thalomid (Thalidomide) capsules: a review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing.

本文引用的文献

1
Expressions of probability: words and numbers.概率的表达:文字与数字。
N Engl J Med. 1980 Feb 14;302(7):411. doi: 10.1056/NEJM198002143020718.
2
Between never and always.
N Engl J Med. 1981 Oct 29;305(18):1097-8.
3
Numbers are better than words. Verbal specifications of frequency have no place in medicine.
Am J Med. 1983 Jun;74(6):1061-5. doi: 10.1016/0002-9343(83)90819-7.
4
沙利度胺胶囊:自发上市后不良事件监测头18个月回顾,包括超适应症用药情况。
Drug Saf. 2001;24(2):87-117. doi: 10.2165/00002018-200124020-00002.
4
Causal or casual? The role of causality assessment in pharmacovigilance.因果关系还是偶然关系?因果关系评估在药物警戒中的作用。
Drug Saf. 1997 Dec;17(6):374-89. doi: 10.2165/00002018-199717060-00004.
5
A risk-benefit assessment of growth hormone use in children.儿童使用生长激素的风险效益评估。
Drug Saf. 1997 Nov;17(5):303-16. doi: 10.2165/00002018-199717050-00003.
6
Health risks of herbal remedies.草药疗法的健康风险。
Drug Saf. 1995 Aug;13(2):81-93. doi: 10.2165/00002018-199513020-00003.
Discovery of new adverse drug reactions. A review of the Food and Drug Administration's spontaneous reporting system.
新的药物不良反应的发现。美国食品药品监督管理局自发报告系统综述。
JAMA. 1984;252(8):1030-3.
5
[Is rechallenge necessary for complete imputability? Comparative value of 7 methods of determining imputability].[完全可归责性是否需要再次激发?确定可归责性的7种方法的比较价值]
Therapie. 1984 Sep-Oct;39(5):461-6.
6
[Significance of the adverbs used to indicate the incidence of the adverse effects of a drug].[用于表明药物不良反应发生率的副词的意义]
Therapie. 1984 Jan-Feb;39(1):62-3.
7
Identification of adverse reactions to new drugs. IV--Verification of suspected adverse reactions.新药不良反应的识别。IV——疑似不良反应的核实。
Br Med J (Clin Res Ed). 1983 Feb 12;286(6364):544-7. doi: 10.1136/bmj.286.6364.544.
8
Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems.新药不良反应的识别。III:警示流程与早期预警系统。
Br Med J (Clin Res Ed). 1983 Feb 5;286(6363):458-60. doi: 10.1136/bmj.286.6363.458.
9
Identification of adverse reactions to new drugs. I: What have been the important adverse reactions since thalidomide?新药不良反应的识别。I:自沙利度胺事件以来有哪些重要的不良反应?
Br Med J (Clin Res Ed). 1983 Jan 15;286(6360):199-202. doi: 10.1136/bmj.286.6360.199.
10
Identification of adverse reactions to new drugs. II--How were 18 important adverse reactions discovered and with what delays?新药不良反应的识别。II——18种重要不良反应是如何被发现的,以及延迟了多久?
Br Med J (Clin Res Ed). 1983 Jan 22;286(6361):289-92. doi: 10.1136/bmj.286.6361.289.